Indo US Bio-Tech Ltd (INDOUS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002989,
    "name": "Indo US Bio-Tech",
    "stock_name": "Indo US Bio-Tech",
    "full_name": "Indo US Bio-Tech Ltd",
    "name_url": "stocks-analysis/indo-us-bio-tech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "93.20",
    "chg": -2.25,
    "chgp": "-2.36%",
    "dir": -1,
    "prev_price": "95.45",
    "mcapval": "191.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541304,
    "symbol": "INDOUS",
    "ind_name": "Other Agricultural Products",
    "ind_code": 61,
    "sector_id": 53,
    "indexname": "India SENSEX",
    "isin": "INE250Z01010",
    "curr_date": "Jun 10, 03:30 PM",
    "curr_time": "19:41 PM",
    "last_traded_at": "Jun 10, 03:30 PM IST",
    "bse_nse_vol": "72.02 k",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indo-us-bio-tech-1002989-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Indo US Bio-Tech Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-falls-to-52-week-low-of-rs-90-amidst-continued-downtrend-4044377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndoUSBioTechLt_priceRelatedfactors_4044377.png",
        "date": "2026-06-10 15:36:33",
        "description": ""
      },
      {
        "title": "Five Consecutive Losses Push Indo US Bio-Tech Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-ltd-stock-falls-to-52-week-low-of-rs94-4033994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IndoUSBioTechLt_priceRelatedfactors_4033994.png",
        "date": "2026-06-03 15:36:29",
        "description": "For the fifth straight session, Indo US Bio-Tech Ltd closed lower, breaching its 52-week low at Rs 94 on 3 Jun 2026, marking a 6.42% decline over the last three days and underperforming its sector by 2.46% today alone."
      },
      {
        "title": "Indo US Bio-Tech Q4 FY26: Margin Compression and Profit Decline Signal Operational Challenges",
        "link": "https://www.marketsmojo.com/news/result-analysis/indo-us-bio-tech-q4-fy26-margin-compression-and-profit-decline-signal-operational-challenges-4024707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndoUSBioTech_quaterlyResult_4024707.png",
        "date": "2026-05-30 23:54:33",
        "description": "Indo US Bio-Tech Ltd., a micro-cap agricultural products company with a market capitalisation of ₹201.00 crores, reported a challenging fourth quarter for FY26, with net profit declining sharply to ₹1.97 crores from ₹3.00 crores in Q3 FY26, marking a 34.33% sequential decline. On a year-on-year basis, the profit contraction was even steeper at 46.47% compared to ₹3.68 crores in Q4 FY25. The stock, currently trading at ₹100.45, has struggled significantly over the past year, declining 41.45% whilst the broader market fell just 8.40%, underscoring deep investor concerns about the company's operational trajectory."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-4020018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndoUSBioTechLt_mojoScore_4020018.png",
        "date": "2026-05-29 10:10:22",
        "description": "Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3996798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndoUSBioTechLt_mojoScore_3996798.png",
        "date": "2026-05-18 10:10:16",
        "description": "Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3979612",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndoUSBioTechLt_mojoScore_3979612.png",
        "date": "2026-05-07 10:10:27",
        "description": "Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3963161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndoUSBioTechLt_mojoScore_3963161.png",
        "date": "2026-04-26 10:10:13",
        "description": "Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3947385",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndoUSBioTechLt_mojoScore_3947385.png",
        "date": "2026-04-15 10:10:17",
        "description": "Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Indo US Bio-Tech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-ltd-is-rated-sell-3932941",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndoUSBioTechLt_mojoScore_3932941.png",
        "date": "2026-04-04 10:10:25",
        "description": "Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 236,
    "sid": "1002989",
    "stock_news_url": "https://www.marketsmojo.com/news/indo-us-bio-tech-1002989"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Newspaper Publication of Audited Financial Results for the Quarter/ Year ended on 31st March 2026. Thanks",
      "source": "BSE"
    },
    {
      "caption": "Results- Financial Results For March 31 2026",
      "datetime": "29-May-2026",
      "details": "Audited Results",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Submission Of Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026.",
      "datetime": "29-May-2026",
      "details": "Audited Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has declared <strong>2%</strong> dividend, ex-date: 03 Dec 24",
          "dt": "2024-12-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Aug 23",
          "dt": "2023-08-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Five Consecutive Losses Push Indo US Bio-Tech Ltd to a New 52-Week Low

2026-06-10 15:36:33

Read full news article

Five Consecutive Losses Push Indo US Bio-Tech Ltd to a New 52-Week Low

2026-06-03 15:36:29

For the fifth straight session, Indo US Bio-Tech Ltd closed lower, breaching its 52-week low at Rs 94 on 3 Jun 2026, marking a 6.42% decline over the last three days and underperforming its sector by 2.46% today alone.

Read full news article

Indo US Bio-Tech Q4 FY26: Margin Compression and Profit Decline Signal Operational Challenges

2026-05-30 23:54:33

Indo US Bio-Tech Ltd., a micro-cap agricultural products company with a market capitalisation of ₹201.00 crores, reported a challenging fourth quarter for FY26, with net profit declining sharply to ₹1.97 crores from ₹3.00 crores in Q3 FY26, marking a 34.33% sequential decline. On a year-on-year basis, the profit contraction was even steeper at 46.47% compared to ₹3.68 crores in Q4 FY25. The stock, currently trading at ₹100.45, has struggled significantly over the past year, declining 41.45% whilst the broader market fell just 8.40%, underscoring deep investor concerns about the company's operational trajectory.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-05-29 10:10:22

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-05-18 10:10:16

Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-05-07 10:10:27

Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-04-26 10:10:13

Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-04-15 10:10:17

Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Read full news article

Indo US Bio-Tech Ltd is Rated Sell

2026-04-04 10:10:25

Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News